Enhancing Patient Outcomes: Prioritizing SGLT2is and GLP-1RAs in Diabetes with CVD

고관표

Diabetes and Metabolism Journal

2024 .03

SGLT2 Inhibitor, an Agent for Diabetes, Heart, Kidney… and Stroke

Taeil Yang ,  Jooyeon Lee ,  Jaewon Oh

Korean Circulation Journal

2024 .09

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

이승아 ,  이동윤

Annals of Pediatirc Endocrinology & Metabolism

2017 .01

Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention: A Systematic Review and Network Meta-Analysis

김지수 ,  Gyeongsil Lee ,  박경일 외 1명

Diabetes and Metabolism Journal

2024 .03

Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study

양예슬 ,  김남훈 ,  백종하 외 13명

Diabetes and Metabolism Journal

2024 .03

SGLT2 Inhibitors: the Gift that Keeps on Giving

Ma ,  ia Victo ,  ia Faith Ga 외 2명

Korean Circulation Journal

2021 .01

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists

Tzu-Yi Lin ,  Eugene Yu-Chuan Kang ,  Shih-Chieh Shao 외 10명

Diabetes and Metabolism Journal

2023 .05

Metformin에 추가로 병용되는 SGLT2 inhibitors의 효능과 안전성에 관한 고찰

정경혜

한국임상약학회지

2018 .01

Superior heart failure protecting effect of selective SGLT2 inhibitor than non-selective SGLT1,2 inhibitor in the diabetic heart failure zebrafish model

Inho Kim

한국실험동물학회 학술발표대회 논문집

2022 .01

Benefits of SGLT2 Inhibitor: Preventing Heart Failure and Beyond

Yong Sook Kim ,  Youngkeun Ahn

Korean Circulation Journal

2019 .01

Cardiovascular Safety of SGLT2 Inhibitors Compared to DPP4 Inhibitors and Sulfonylureas as the Second-Line of Therapy in T2DM Using Large, Real-World Clinical Data in Korea

김규호 ,  최성희

Diabetes and Metabolism Journal

2021 .01

Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-Induced Heart Failure

Chang-Myung Oh

Korean Circulation Journal

2019 .01

Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists

최훈지 ,  조영민

Endocrinology and Metabolism

2021 .01

Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: a Korean Diabetes Association and Korean Society of Nephrology consensus statement

오태정 ,  문주영 ,  Kyu Yeon Hu 외 13명

Kidney Research and Clinical Practice

2020 .01

제2형 당뇨병 환자에서 Metformin과 병용한 Sodium-Glucose Cotransporter 2 Inhibitors와 Dipeptidyl Peptidase 4 Inhibitors의 효능 비교

박소연 ,  유다혜 ,  권지은 외 3명

병원약사회지

2020 .01

당뇨병을 동반하지 않는 심부전 환자에서 SGLT2 Inhibitor의 심장기능에 대한 효과

이하늘 ,  이해원 ,  금민정 외 4명

병원약사회지

2024 .08

A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans

Jack Alistai ,  Sa ,  geant 외 5명

Endocrinology and Metabolism

2019 .01

GLP-1 Based Combination Therapy for Obesity and Diabetes

이영희 ,  Hee Won Lee ,  최형진

Journal of Obesity & Metabolic Syndrome

2017 .01

Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Weight Reduction in Overweight and Obese Populations without Diabetes: A Systematic Review and a Meta-Analysis

조윤경 ,  김예지 ,  정창희

Journal of Obesity & Metabolic Syndrome

2021 .12

Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus

이승은 ,  Nam Hyewon ,  최한석 외 3명

Diabetes and Metabolism Journal

2022 .07